Nephrotic syndrome associated with anti-tumor necrosis factor α therapy in a patient with rheumatoid arthritis:: comment on the article by Charles et al -: Reply

被引：0
|
作者：
Maini, RN [1 ]
Charles, P [1 ]
机构：
[1] Univ London Imperial Coll Sci Technol & Med, Kennedy Inst Rheumatol Div, London, England
来源：
ARTHRITIS AND RHEUMATISM | 2002年 / 46卷 / 06期
关键词：
D O I：
10.1002/art.10350
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1693 / 1693
页数：1
相关论文
共 50 条
  • [21] Interactions between rheumatoid arthritis antibodies are associated with the response to anti-tumor necrosis factor therapy
    Julia, Antonio
    Lopez-Lasanta, Maria
    Blanco, Francisco
    Gomez, Antonio
    Haro, Isabel
    Mas, Antonio Juan
    Erra, Alba
    Vivar, Ma Luz Garcia
    Monfort, Jordi
    Sanchez-Fernandez, Simon
    Gonzalez, Isidoro
    Alperi, Mercedes
    Castellanos-Moreira, Raul
    Fernandez-Nebro, Antonio
    Diaz-Torne, Cesar
    Palau, Nuria
    Lastra, Raquel
    Llados, Jordi
    Sanmarti, Raimon
    Marsal, Sara
    BMC MUSCULOSKELETAL DISORDERS, 2021, 22 (01)
  • [22] Interactions between rheumatoid arthritis antibodies are associated with the response to anti-tumor necrosis factor therapy
    Antonio Julià
    María López-Lasanta
    Francisco Blanco
    Antonio Gómez
    Isabel Haro
    Antonio Juan Mas
    Alba Erra
    Ma Luz García Vivar
    Jordi Monfort
    Simón Sánchez-Fernández
    Isidoro González
    Mercedes Alperi
    Raúl Castellanos-Moreira
    Antonio Fernández-Nebro
    César Díaz-Torné
    Núria Palau
    Raquel Lastra
    Jordi Lladós
    Raimon Sanmartí
    Sara Marsal
    BMC Musculoskeletal Disorders, 22
  • [23] Anti-Tumor Necrosis Factor Therapy in Rheumatoid Arthritis Patients Are Not Associated with Increased Lymphoma Risk
    Wong, A. K.
    Kerkoutian, S.
    Said, J. W.
    Rashidi, H.
    Pullarkat, S. T.
    MODERN PATHOLOGY, 2010, 23 : 329A - 329A
  • [24] Anti-Tumor Necrosis Factor Therapy in Rheumatoid Arthritis Patients Are Not Associated with Increased Lymphoma Risk
    Wong, A. K.
    Kerkoutian, S.
    Said, J. W.
    Rashidi, H.
    Pullarkat, S. T.
    LABORATORY INVESTIGATION, 2010, 90 : 329A - 329A
  • [25] Tumor necrosis factor antagonist-associated neutropenia: comment on the article by Hastings et al Reply
    Hastings, Richard
    Ding, Tina
    Deighton, Chris
    ARTHRITIS CARE & RESEARCH, 2010, 62 (12) : 1815 - 1815
  • [26] Similarities in the mechanisms of action of pulse corticosteroids and anti-tumor necrosis factor α therapy in rheumatoid arthritis -: Reply
    Maini, RN
    Feldmann, M
    ARTHRITIS AND RHEUMATISM, 1998, 41 (03): : 565 - 565
  • [27] Multicentric reticulohistiocytosis treated successfully with an anti-tumor necrosis factor agent: comment on the article by Gorman et al
    Matejicka, C
    Morgan, GJ
    Schlegelmilch, JG
    ARTHRITIS AND RHEUMATISM, 2003, 48 (03): : 864 - 866
  • [28] Breast Lymphoma Complicating Anti-Tumor Necrosis Factor Therapy in Rheumatoid Arthritis
    Pattanaik, Debendra
    Koduru, Swapna
    Azouz, Abdallah
    Patil, Sadanand
    Carbone, Laura
    CLINICAL BREAST CANCER, 2011, 11 (06) : 413 - 416
  • [29] Anti-tumor necrosis factor-α monoclonal antibody therapy for rheumatoid arthritis
    Kavanaugh, AF
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 1998, 24 (03) : 593 - +
  • [30] GENDER DIFFERENCES IN RHEUMATOID ARTHRITIS: EFFECT OF ANTI-TUMOR NECROSIS FACTOR THERAPY
    Gioia, Chiara
    Spinelli, Francesca
    Priori, Roberta
    Iannuccelli, Cristina
    Lucchino, Bruno
    Vestri, Annarita
    Valesini, Guido
    DI Franco, Manuela
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 1650 - 1650
12345